The Food and Drug Administration yesterday alerted health care providers and the public to three COVID-19 antigen tests that are not authorized or approved for distribution or use in the United States. Due to the potential for false results, FDA said providers should consider retesting patients with an authorized test if these tests was performed less than two weeks ago and they suspect an inaccurate result. 

In other testing news, President Biden last night announced that Americans will be able to order four more free at-home COVID-19 tests starting next week. 

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…